Arid
DOI10.1007/s40121-022-00606-y
Coccidioidomycosis: A Contemporary Review
Crum, Nancy F.
通讯作者Crum, NF (corresponding author),Scripps Hlth Syst, Infect Dis Dept, San Diego, CA 92127 USA.
来源期刊INFECTIOUS DISEASES AND THERAPY
ISSN2193-8229
EISSN2193-6382
出版年2022-03
英文摘要Coccidioidomycosis, colloquially known as Valley Fever, is an invasive dimorphic fungal infection caused by Coccidioides immitis and C. posadasii. The fungi are found in the arid desert soils of the southwestern US, as well as in parts of Mexico and Central and South America. Acquisition is typically via inhalation of arthroconidia which become airborne after both natural (e.g., earthquakes, dust storms, and fires) and human-related events (e.g., military maneuvers, recreational activities, agriculture, and construction). The incidence of infection in increasing likely a result of both climatic and populational changes. Further, the recognized geographic distribution of Coccidioides spp. is expanding, as cases are being diagnosed in new areas (e.g., eastern Washington, Oregon, and Utah). Most coccidioidal infections are asymptomatic (60%); however, approximately one-third develop a pulmonary illness which is a leading cause of community-acquired pneumonia in highly endemic areas. Uncommonly (0.5-2% of cases), the infection disseminates to extrapulmonary locations (e.g., skin, bones/joints, and the central nervous system), and is most commonly seen among persons with cellular immunodeficiencies (e.g., transplant recipients, HIV, and pregnancy) and non-Caucasian races (especially African Americans and Filipinos). The diagnosis of coccidioidomycosis requires astute clinical suspicion and laboratory findings, including positive serology, cultures, and/or histopathology results. Treatment is warranted among persons with pneumonia who have risk factors for complicated disease and among those with extrapulmonary disease. Novel antifungals with improved fungicidal activity and rapidity of action with fewer side effects and drug interactions are needed. Preventive strategies (e.g., education regarding the disease, dust avoidance, mask wearing, including among select groups, antifungal prophylaxis, and surveillance laboratory testing) are advised for residents and travelers to endemic areas. Currently, no preventive vaccine is available. Coccidioidomycosis has been recognized for over a century, and an expanding wealth of knowledge has been gained regarding this emerging infectious disease which will be reviewed here.
英文关键词Coccidioidomycosis Coccidioides Valley fever Endemic mycosis Review
类型Review ; Early Access
语种英语
开放获取类型Green Accepted, gold
收录类别SCI-E
WOS记录号WOS:000762890700001
WOS关键词DELAYED-TYPE HYPERSENSITIVITY ; VITRO ANTIFUNGAL ACTIVITY ; IMMITIS-ENDEMIC AREA ; UNITED-STATES ; IN-VITRO ; REFRACTORY COCCIDIOIDOMYCOSIS ; PULMONARY COCCIDIOIDOMYCOSIS ; ORAL FLUCONAZOLE ; NIKKOMYCIN Z ; ACTIVE COCCIDIOIDOMYCOSIS
WOS类目Infectious Diseases
WOS研究方向Infectious Diseases
资源类型期刊论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/377383
作者单位[Crum, Nancy F.] Scripps Hlth Syst, Infect Dis Dept, San Diego, CA 92127 USA
推荐引用方式
GB/T 7714
Crum, Nancy F.. Coccidioidomycosis: A Contemporary Review[J],2022.
APA Crum, Nancy F..(2022).Coccidioidomycosis: A Contemporary Review.INFECTIOUS DISEASES AND THERAPY.
MLA Crum, Nancy F.."Coccidioidomycosis: A Contemporary Review".INFECTIOUS DISEASES AND THERAPY (2022).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Crum, Nancy F.]的文章
百度学术
百度学术中相似的文章
[Crum, Nancy F.]的文章
必应学术
必应学术中相似的文章
[Crum, Nancy F.]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。